A detailed history of Sapient Capital LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Sapient Capital LLC holds 134,020 shares of BSX stock, worth $12.1 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
134,020
Previous 138,211 3.03%
Holding current value
$12.1 Million
Previous $10.6 Million 5.52%
% of portfolio
0.23%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$72.96 - $84.0 $305,775 - $352,044
-4,191 Reduced 3.03%
134,020 $11.2 Million
Q2 2024

Jul 15, 2024

SELL
$67.33 - $77.71 $66,858 - $77,166
-993 Reduced 0.71%
138,211 $10.6 Million
Q1 2024

Apr 22, 2024

SELL
$57.6 - $68.62 $70,156 - $83,579
-1,218 Reduced 0.87%
139,204 $9.53 Billion
Q4 2023

Feb 06, 2024

BUY
$48.64 - $57.81 $661,309 - $785,984
13,596 Added 10.72%
140,422 $8.12 Billion
Q4 2023

Jan 29, 2024

BUY
$48.64 - $57.81 $6.17 Million - $7.33 Million
126,826 New
126,826 $7.33 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Sapient Capital LLC Portfolio

Follow Sapient Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sapient Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sapient Capital LLC with notifications on news.